OptimizeRx (OPRX) Long-Term Deferred Tax (2018 - 2024)

OptimizeRx's Long-Term Deferred Tax history runs 7 years deep, the most recent figure standing at $4.5 million for Q4 2024.

• In Q4 2024, Long-Term Deferred Tax rose 3.55% year-over-year to $4.5 million; the TTM figure through Dec 2024 stood at $4.5 million (up 3.55% YoY), while the FY2024 annual figure was $4.5 million, up 3.55% from the prior year.
• Long-Term Deferred Tax came in at $4.5 million for Q4 2024 at OptimizeRx, up from $4.3 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 million in Q4 2022 to a low of $2.3 million in Q4 2020.
• A 5-year average of $5.9 million and a median of $4.5 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax soared 249.22% in 2021 and slumped 58.66% in 2023, its largest moves.
• OptimizeRx's Long-Term Deferred Tax stood at $2.3 million in 2020, then jumped by 249.22% to $7.9 million in 2021, then jumped by 33.11% to $10.5 million in 2022, then plunged by 58.66% to $4.3 million in 2023, then gained by 3.55% to $4.5 million in 2024.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.5 million, $4.3 million, and $10.5 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison